Guidance, NICE advice and quality standards In development
Showing 1 to 3 of 3
Title | Type | Expected publication date |
---|---|---|
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222] | Technology appraisal guidance | |
Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease ID6343 | Technology appraisal guidance | TBC |
Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043] | Technology appraisal guidance | TBC |